News

Avitide, Inc., the industry leader in the discovery and development of custom affinity purification resins, announces that it has entered into an exclusive license agreement to support…
Read More...

MetP Pharma AG announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Treatment of Demyelinating…
Read More...

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved AVSOLA (infliximab-axxq) for all approved indications of the reference product, Remicade (infliximab): for…
Read More...

Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to the investigational…
Read More...

Amgen announced that it has entered into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's…
Read More...

Tmunity Therapeutics, in pursuit of its vision to save and improve lives by delivering the full potential of next-generation T-cell immunotherapy, closed a $75 million Series B…
Read More...

Dicerna Pharmaceuticals, Inc. announced a research collaboration and licensing agreement with Roche to develop novel therapies for the treatment of chronic hepatitis B virus (HBV)…
Read More...

Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute (Sarah Cannon) announced that the first patient has been dosed in a first-in-human phase 1/2 study evaluating…
Read More...

NuChem Therapeutics, a drug discovery and development contract research organization (CRO) located in Montreal, specializing in synthetic and medicinal chemistry services, has just…
Read More...

AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe…
Read More...

Novartis announced the United States Food & Drug Administration (FDA) placed a partial hold on clinical trials for intrathecal administration of AVXS-101. The announcement follows…
Read More...

Pandion Therapeutics and Astellas Pharma announced the signing of a License and Collaboration Agreement directed toward the research, development, and commercialization of locally…
Read More...

Biogen Inc. and Alkermes plc announced that the U.S. Food and Drug Administration (FDA) approved VUMERITY (diroximel fumarate), a novel oral fumarate with a distinct chemical structure,…
Read More...

Roche announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) for satralizumab for the treatment of adult and adolescent…
Read More...

Pascal Biosciences Inc. and Y-Biologics announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia.…
Read More...

ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system…
Read More...

Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease,…
Read More...

Boehringer Ingelheim presented promising preclinical data from its pan-KRAS program including the novel, oral inhibitor BI 1701963 at the AACR-NCI-EORTC International Conference on…
Read More...

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’…
Read More...

The European Commission (EC) approved a new indication for Dupixent (dupilumab) in chronic rhinosinusitis with nasal polyposis (CRSwNP). Dupixent is indicated as an add-on therapy with…
Read More...